Icaritin Suppresses Multiple Myeloma, by Inhibiting IL-6/JAK2/STAT3

Oncotarget - United States
doi 10.18632/oncotarget.3399
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Ibrutinib Targets microRNA-21 in Multiple Myeloma Cells by Inhibiting NF-κB and STAT3

Tumor Biology
MedicineCancer Research
2018English

MiR-125a-5p Decreases the Sensitivity of Treg Cells Toward IL-6-Mediated Conversion by Inhibiting IL-6R and STAT3 Expression

Scientific Reports
Multidisciplinary
2015English

Screening of JAK2 V617F Mutation in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Electroacupuncture Attenuates Visceral Hypersensitivity by Inhibiting JAK2/STAT3 Signaling Pathway in the Descending Pain Modulation System

Frontiers in Neuroscience
Neuroscience
2017English

IL-6-induced Enhancement of C-Myc Translation in Multiple Myeloma Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Pantoprazole Blocks the JAK2/STAT3 Pathway to Alleviate Skeletal Muscle Wasting in Cancer Cachexia by Inhibiting Inflammatory Response

Oncotarget
Oncology
2017English

Autophagy Impacts on Oxaliplatin-Induced Hepatocarcinoma Apoptosis via the IL-17/IL-17R-JAK2/STAT3 Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2016English

Circ-Smarca5 Suppresses Progression of Multiple Myeloma by Targeting miR-767-5p

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Regulation of STAT3 and NF-κB Activations by S-Nitrosylation in Multiple Myeloma

Free Radical Biology and Medicine
BiochemistryPhysiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy